>>> US Research Calls

Research Calls I
  • Upgrades:
    • AN2 Therapeutics (ANTX) upgraded to Mkt Outperform from Mkt Perform at JMP Securities; tgt $6
    • Array Tech (ARRY) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $18
    • Blue Owl Capital (OWL) upgraded to Buy from Neutral at UBS; tgt raised to $22
    • Brown-Forman (BF.B) upgraded to Neutral from Sell at Citigroup; tgt $52
    • Eaton (ETN) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $300
    • Estee Lauder (EL) upgraded to Buy from Neutral at Citigroup; tgt raised to $175
    • Home Depot (HD) upgraded to Outperform from Neutral at Zelman
    • McCormick (MKC) upgraded to Buy from Hold at Argus
    • Moody's (MCO) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $450
    • National Grid (NGG) upgraded to Outperform from Underperform at Exane BNP Paribas
    • StoneCo (STNE) upgraded to Outperform from Neutral at Bradesco BBI
  • Downgrades:
    • BCE Inc (BCE) downgraded to Market Perform from Outperform at BMO Capital Markets
    • Biomea Fusion (BMEA) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $14
    • Blackstone (BX) downgraded to Neutral from Buy at UBS; tgt lowered to $135
    • Century Communities (CCS) downgraded to Underperform from Neutral at Wedbush; tgt lowered to $82
    • Clorox (CLX) downgraded to Neutral from Buy at Citigroup; tgt lowered to $165
    • FIGS, Inc. (FIGS) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $4.50
    • Lennar (LEN) downgraded to Underperform from Neutral at Wedbush; tgt $144
    • LGI Homes (LGIH) downgraded to Underperform from Neutral at Wedbush; tgt lowered to $74
    • Lowe's (LOW) downgraded to Neutral from Outperform at Zelman
    • Meritage (MTH) downgraded to Underperform from Neutral at Wedbush; tgt lowered to $148
    • Microvast (MVST) downgraded to Neutral from Buy at Janney
    • Nextracker (NXT) downgraded to Equal Weight from Overweight at Barclays; tgt raised to $63
    • NIO (NIO) downgraded to Underweight from Equal Weight at Barclays; tgt $4
    • Petco Health and Wellness (WOOF) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $1.50
    • Porsche (POAHY) downgraded to Neutral from Buy at UBS
    • Ultrapar Participacoes (UGP) downgraded to Market Perform from Outperform at Itau BBA
  • Others:
    • Annaly Capital Mgmt (NLY) initiated with a Buy at Compass Point; tgt $22
    • Grindr (GRND) initiated with a Mkt Outperform at JMP Securities; tgt $14
    • Marqeta (MQ) initiated with a Buy at Monness Crespi & Hardt; tgt $7.50
    • Mineralys Therapeutics (MLYS) initiated with a Buy at Goldman; tgt $30
    • MoonLake Immunotherapeutics (MLTX) initiated with a Neutral at Goldman; tgt $62
    • Olema Pharmaceuticals (OLMA) initiated with a Buy at Goldman; tgt $24
    • Otis Worldwide (OTIS) initiated with a Hold at Melius
    • PowerFleet (PWFL) initiated with an Outperform at Raymond James; tgt $7
    • Q32 Bio (QTTB) initiated with an Overweight at Piper Sandler; tgt $45
    • Rocket Pharmaceuticals (RCKT) initiated with a Neutral at Goldman; tgt $39
    • Solventum Corporation (SOLV) initiated with a Hold at Edward Jones
    • Zebra Tech (ZBRA) initiated with an Equal Weight at Barclays; tgt $292